These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15443508)

  • 21. [Remote results of arsenoxide and novarsenol treatment of acute contagious forms of syphilis].
    MEMORSKY VP
    Vestn Venerol Dermatol; 1948; 29(1):25-7. PubMed ID: 18887739
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxic effects of arsenical compounds as employed in the treatment of syphilis in the United States Navy 1945.
    BURTON OL; JUSTYN GW; ANDERSON LT
    U S Nav Med Bull; 1947; 47(1):180-97. PubMed ID: 20284337
    [No Abstract]   [Full Text] [Related]  

  • 23. [Accumulation of arsenic in the organs of the rabbit in experimental syphilis].
    APASOVA EI
    Vestn Venerol Dermatol; 1945; (2):23-7. PubMed ID: 20280567
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of treatment of contagious forms of syphilis using the American preparation mapharsen].
    MEMORSKY VP; ZERNOVA MG
    Vestn Venerol Dermatol; 1945; (2):18-23. PubMed ID: 20280566
    [No Abstract]   [Full Text] [Related]  

  • 25. The synergistic action of penicillin and mapharsen (oxophenarsine hydrochloride) in the treatment of experimental syphilis.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Vener Dis Inf; 1946 Jan; 27():3-9. PubMed ID: 21009441
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of early syphilis by the twenty-six-week mapharsen-bismuth schedule.
    STERNBERG TH; LEIFER W
    Am J Syph Gonorrhea Vener Dis; 1947 Mar; 31(2):124-34. PubMed ID: 20289292
    [No Abstract]   [Full Text] [Related]  

  • 27. Observations on 360 cases of primary syphilis (treated with penicillin alone or with penicillin plus mapharsen and bismuth).
    JONES EH
    Ohio State Med J; 1951 Feb; 47(2):131-3. PubMed ID: 14807370
    [No Abstract]   [Full Text] [Related]  

  • 28. BAL in the treatment of massive overdosage with mapharsen.
    ARMSTRONG CD; FLEMING WJ; THALMANN WG
    Calif Med; 1948 Oct; 69(4):247-52. PubMed ID: 18884800
    [No Abstract]   [Full Text] [Related]  

  • 29. Pulmonary syphilis; course of mapharside; recovery.
    HUMPHRIES SV
    Proc Transvaal Mine Med Off Assoc; 1947-1948; 27(299):103. PubMed ID: 18939099
    [No Abstract]   [Full Text] [Related]  

  • 30. [Arsenoxides in the therapy of syphilis].
    WEIN MA; ROSENTUL MA
    Vestn Venerol Dermatol; 1945; (1):16-21. PubMed ID: 20280556
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapy of early syphilis with artificial fever in combination with mapharsen, bismuth, and penicillin.
    O'BRIEN JF; RODRIQUEZ J; SMITH CA; SCHWEMLEIN GX
    Am J Syph Gonorrhea Vener Dis; 1952 Sep; 36(5):451-6. PubMed ID: 14952686
    [No Abstract]   [Full Text] [Related]  

  • 32. [Arsenoxide prophylaxis of transfusion syphilis].
    SCHWALM H
    Klin Wochenschr; 1951 May; 29(17-18):319-20. PubMed ID: 14842027
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical results and by effects in early syphilis with combined arsenical-bismuth treatment.
    MØLLER P
    Acta Derm Venereol Suppl (Stockh); 1950 Sep 4-10; 31(Suppl. 24):30-41. PubMed ID: 14829187
    [No Abstract]   [Full Text] [Related]  

  • 34. Penicillin versus arsenical-bismuth treatment in early syphilis.
    PERDRUP A
    Acta Derm Venereol Suppl (Stockh); 1950 Sep 4-10; 31(Suppl. 24):44-8. PubMed ID: 14829189
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of the treatment of early syphilis by maximal arsenic-bismuth therapy; inquiry conducted in the official antivenereal services of Spain].
    GAY PRIETO J; CORDERO SOROA A
    Actas Dermosifiliogr; 1953 Jan; 44(4):244-54. PubMed ID: 13050531
    [No Abstract]   [Full Text] [Related]  

  • 36. Time relationships in the reversal by BAL of the chemotherapeutic effect of mapharsen.
    PFEIFFER CC; JENNEY EH; ROSS CA
    Fed Proc; 1947; 6(1):363. PubMed ID: 20249608
    [No Abstract]   [Full Text] [Related]  

  • 37. The intensive treatment of early syphilis: in 9 to 15 weeks with triweekly injections of mapharsen (oxophenarsine hydrochloride) and concomitant weekly injections of bismuth: an analysis of the results in 110 cases.
    DEXTER DD
    Am J Syph Gonorrhea Vener Dis; 1947 Sep; 31(5):533-41. PubMed ID: 20262385
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of the examination of 1340 primary-secondary syphilitics who followed regular arsenobismuth and bismuth treatment for a minimum of 4 years].
    DEGOS R; VISSIAN L; BASSET H
    Bull Soc Fr Dermatol Syphiligr; 1950; 57(2):209-11. PubMed ID: 15434640
    [No Abstract]   [Full Text] [Related]  

  • 39. Trypanocidal and spirochetocidal compounds derived from BAL and organic arsenicals.
    FRIEDHEIM EA; VOGEL HJ
    Proc Soc Exp Biol Med; 1947 Apr; 64(4):418. PubMed ID: 20239441
    [No Abstract]   [Full Text] [Related]  

  • 40. [Syphilis, general paralysis and arsenical therapy].
    BOREL J; DARIOSECQ
    Concours Med; 1950 Sep; 72(36):2635-7. PubMed ID: 14773164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.